20 June 2013
Keywords: chmp, recommends, revoking, approval, visudyne, cnv, canadian
Article | 30 April 2007
Canadian biopharmaceutical firm QLT says that the European Medicnies Agency's Committee for Medicinal Products for Human Use (CHMP) will
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
30 April 2007
7 May 2007
19 June 2013
© 2013 thepharmaletter.com